Pfizer, Moderna vaccines effective against Indian variants: study. The lab-based study was carried out by the NYU Grossman School of Medicine and NYU Langone Center and is preliminary because it has not yet been published in a peer-reviewed journal. Full story: http://u.afp.com/UeMB
Read More
Real-world effectiveness “easily as good, if not better” than trials Growing real-world evidence suggests that available COVID-19 vaccines are highly protective against known SARS-CoV-2 strains, including those designated as variants of concern by the CDC, according to NIAID Director Anthony Fauci, MD. In the opening keynote address at the American Thoracic […]
Read More
Although fewer children have been infected with COVID-19 compared to adults, children can be infected with the virus that causes COVID-19, can get sick from COVID-19, and can spread COVID-19 to others. CDC recommends COVID-19 vaccination for everyone 12 years of age and older to help protect against COVID-19. Children 12 years of age […]
Read More
Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines approved for use under an Emergency Use Authorization (EUA) in the United States (1–3). In an evaluation at 24 hospitals in 14 states,* the […]
Read More
COVID-19 vaccines are more widely accessible. Everyone 16 years and older is now eligible to be vaccinated. As of April 26, 2021, more than 140 million people across the United States had received at least one dose of COVID-19 vaccine. Of those, more than 95 million are fully vaccinated. If […]
Read More
As of April 12, 2021, almost 121 million people across the United States had received at least one dose of COVID-19 vaccine. Of those, more than 74 million are fully vaccinated. If you haven’t gotten vaccinated yet, get a COVID-19 vaccine when it’s available to you. After you’ve been fully […]
Read More
Issues of Viral Variants and Vaccine Efficacy The efforts of the Biden administration to accelerate rollout of COVID-19 vaccines are enabling more adults in the US to be vaccinated each week. As of February 28, 2021, an estimated more than 48 million people have received at least 1 vaccine dose. […]
Read More
(Reuters) – Antibodies induced by the Pfizer/BioNTech and Moderna vaccines and the antibody therapy from Regeneron Pharmaceuticals all are able to neutralize a coronavirus variant on the rise in New York, lab experiments show. The New York variant contains mutations – E484K, S477N and D235G – that experts feared might […]
Read More
As the virus that causes COVID-19 continues to evolve, drugmakers are racing to adapt their vaccines to the changes in the virus’ genetic code that appear to help it escape our immune defenses. Of the three “variants of concern” recognized by the World Health Organization and Centers for Disease Control […]
Read More